Log In
Print
BCIQ
Print
Print this Print this
 

Staphylococcus lysin (CF-301)

  Manage Alerts
Collapse Summary General Information
Company ContraFect Corp.
DescriptionStaphyloccoccal specific lysin protein
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPreclinical
Standard IndicationStaphylococcus
Indication DetailsTreat acute bacterial skin and skin structure infections (ABSSSI) caused by Staphylococcus aureus; Treat staphylococcus
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today